QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
QQQ   354.21 (-1.50%)
AAPL   171.96 (-2.34%)
MSFT   312.14 (-1.70%)
META   298.96 (-0.62%)
GOOGL   128.57 (-1.94%)
AMZN   125.98 (-4.03%)
TSLA   244.12 (-1.16%)
NVDA   419.11 (-0.74%)
NIO   8.40 (+0.60%)
BABA   85.88 (-1.54%)
AMD   95.96 (-1.46%)
T   15.02 (-0.27%)
F   12.44 (-1.11%)
MU   67.94 (-0.93%)
CGC   0.92 (-2.12%)
GE   109.94 (-1.59%)
DIS   80.04 (-1.20%)
AMC   7.92 (-2.82%)
PFE   32.37 (-1.85%)
PYPL   58.93 (+0.12%)
NFLX   379.25 (-1.44%)
Positive News SentimentPositive News
NASDAQ:SERA

Sera Prognostics (SERA) Stock Forecast, Price & News

$1.91
+0.13 (+7.30%)
(As of 09/26/2023 ET)
Compare
Today's Range
$1.73
▼
$1.95
50-Day Range
$1.55
▼
$3.24
52-Week Range
$1.10
▼
$4.25
Volume
88,753 shs
Average Volume
487,499 shs
Market Capitalization
$59.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.75
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Sera Prognostics MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
44.0% Upside
$2.75 Price Target
Short Interest
Healthy
0.84% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.75mentions of Sera Prognostics in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($1.28) to ($1.30) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

365th out of 964 stocks

Medical Laboratories Industry

10th out of 23 stocks

See Top Rated MarketRank™ Stocks Here

SERA stock logo

About Sera Prognostics (NASDAQ:SERA) Stock

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

SERA Price History

SERA Stock News Headlines

September 21, 2023 | finance.yahoo.com
SERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023
August 31, 2023 | finance.yahoo.com
Sera Prognostics, Inc. (SERA) Loses -32.38% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
September 26, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
August 30, 2023 | finance.yahoo.com
Sera Prognostics, Inc. (SERA) Loses -38.49% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
August 16, 2023 | finanznachrichten.de
Sera Prognostics, Inc.: Sera Prognostics Reports Second Quarter 2023 Financial Results
August 11, 2023 | msn.com
Citigroup Maintains Sera Prognostics Inc (SERA) Neutral Recommendation
August 9, 2023 | finance.yahoo.com
SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
August 9, 2023 | finance.yahoo.com
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Tops Revenue Estimates
September 26, 2023 | Legacy Research (Ad)
WARNING: Mandatory U.S. Dollar Recall is Weeks Away
If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.
July 31, 2023 | finance.yahoo.com
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023
June 28, 2023 | fool.com
Sera Prognostics (NASDAQ: SERA)
June 8, 2023 | msn.com
Sera Prognostics: Buy The PreTRM Moat
May 25, 2023 | marketwatch.com
Sera Prognostics Reduces Headcount to Cut Costs in Optimization Strategy
May 25, 2023 | finance.yahoo.com
Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue
May 15, 2023 | msn.com
Sera Prognostics CEO Critchfield to step down in June
May 15, 2023 | finance.yahoo.com
Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO
May 11, 2023 | finanznachrichten.de
Sera Prognostics, Inc.: Sera Prognostics Reports First Quarter 2023 Financial Results
May 10, 2023 | msn.com
Recap: Sera Prognostics Q1 Earnings
May 10, 2023 | finance.yahoo.com
SERA PROGNOSTICS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
May 10, 2023 | finance.yahoo.com
Sera Prognostics, Inc. (SERA) Reports Q1 Loss
May 10, 2023 | marketwatch.com
Premature Rupture of Membranes (PROM) Testing Market Report | Research Across The World 2031
May 3, 2023 | benzinga.com
Sera Prognostics Stock (NASDAQ:SERA), Dividends
April 27, 2023 | finance.yahoo.com
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2023 Financial Results on May 10, 2023
April 24, 2023 | finance.yahoo.com
Sera Prognostics, Inc. (SERA) Loses -13.03% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
March 27, 2023 | finance.yahoo.com
All You Need to Know About Sera Prognostics, Inc. (SERA) Rating Upgrade to Buy
March 27, 2023 | marketwatch.com
Latest Premature Rupture of Membranes (PROM) Testing Market Growth Outlook 2023-2030 | New Report Highlights
March 27, 2023 | insidermonkey.com
Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2022 Earnings Call Transcript
See More Headlines
Receive SERA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sera Prognostics and its competitors with MarketBeat's FREE daily newsletter.

SERA Company Calendar

Last Earnings
8/09/2023
Today
9/26/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SERA
CUSIP
N/A
CIK
1534969
Web
www.seraprognostics.com
Phone
801-990-0520
Fax
N/A
Employees
87
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$2.75
High Stock Price Forecast
$2.75
Low Stock Price Forecast
$2.75
Forecasted Upside/Downside
+45.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($1.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-44,190,000.00
Net Margins
-11,084.00%
Pretax Margin
-11,084.00%
Return on Equity
-44.05%
Return on Assets
-38.21%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
4.54
Quick Ratio
4.54

Sales & Book Value

Annual Sales
$270,000.00
Price / Sales
218.96
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.19 per share
Price / Book
0.59

Miscellaneous

Outstanding Shares
31,280,000
Free Float
26,403,000
Market Cap
$59.12 million
Optionable
Not Optionable
Beta
0.33
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Ms. Evguenia Lindgardt M.B.A. (Age 49)
    Interim Pres, CEO & Director
    Comp: $37.5k
  • Dr. Gregory C. Critchfield M.D. (Age 70)
    M.S., Exec. Director
    Comp: $790.74k
  • Dr. Steven W. Graves
    Co-Founder and Co-Chairman of The Scientific Advisory Board
  • Dr. M. Sean Esplin M.D.
    Co-Founder and Co-Chairman of Scientific Advisory Board
  • Mr. Austin Aerts
    Chief Financial Officer??
  • Dr. John J. Boniface Ph.D. (Age 61)
    Chief Scientific Officer
  • Mr. Robert G. Harrison (Age 57)
    Chief Information Officer
  • Mr. Benjamin G. Jackson J.D. (Age 44)
    Gen. Counsel
  • Dr. Paul Kearney Ph.D. (Age 55)
    Chief Data Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













SERA Stock - Frequently Asked Questions

Should I buy or sell Sera Prognostics stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sera Prognostics in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SERA shares.
View SERA analyst ratings or view top-rated stocks.

What is Sera Prognostics' stock price forecast for 2023?

2 Wall Street research analysts have issued 1-year price objectives for Sera Prognostics' shares. Their SERA share price forecasts range from $2.75 to $2.75. On average, they predict the company's share price to reach $2.75 in the next year. This suggests a possible upside of 45.5% from the stock's current price.
View analysts price targets for SERA or view top-rated stocks among Wall Street analysts.

How have SERA shares performed in 2023?

Sera Prognostics' stock was trading at $1.26 on January 1st, 2023. Since then, SERA stock has increased by 50.0% and is now trading at $1.89.
View the best growth stocks for 2023 here.

When is Sera Prognostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our SERA earnings forecast.

How were Sera Prognostics' earnings last quarter?

Sera Prognostics, Inc. (NASDAQ:SERA) announced its quarterly earnings results on Wednesday, August, 9th. The company reported ($0.34) EPS for the quarter, meeting the consensus estimate of ($0.34). The business had revenue of $0.12 million for the quarter, compared to analysts' expectations of $0.10 million. Sera Prognostics had a negative net margin of 11,084.00% and a negative trailing twelve-month return on equity of 44.05%.

When did Sera Prognostics IPO?

(SERA) raised $75 million in an initial public offering (IPO) on Thursday, July 15th 2021. The company issued 4,687,500 shares at a price of $15.00-$17.00 per share.

What is Sera Prognostics' stock symbol?

Sera Prognostics trades on the NASDAQ under the ticker symbol "SERA."

Who are Sera Prognostics' major shareholders?

Sera Prognostics' stock is owned by many different retail and institutional investors. Top institutional investors include Sanders Morris Harris LLC (1.17%), BlackRock Inc. (0.19%), Marquette Asset Management LLC (0.11%) and Citadel Advisors LLC (0.04%). Insiders that own company stock include Benjamin Jackson, John J Boniface and Robert Gardner Harrison.
View institutional ownership trends.

How do I buy shares of Sera Prognostics?

Shares of SERA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sera Prognostics' stock price today?

One share of SERA stock can currently be purchased for approximately $1.89.

How much money does Sera Prognostics make?

Sera Prognostics (NASDAQ:SERA) has a market capitalization of $59.12 million and generates $270,000.00 in revenue each year. The company earns $-44,190,000.00 in net income (profit) each year or ($1.34) on an earnings per share basis.

How can I contact Sera Prognostics?

The official website for the company is www.seraprognostics.com. The company can be reached via phone at 801-990-0520 or via email at peter@capcommpartners.com.

This page (NASDAQ:SERA) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -